Press Releases Items Per Page 102550 News Category FinancialGeneral Year None2024202320222021202020192018201720162015201420132012201120102009200820072006 Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients Apr 09, 2008 Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results Feb 27, 2008 Nektar to Announce 2007 Year-End Financial Results on Wednesday, February 27, 2008, After Close of U.S.-Based Financial Markets Feb 21, 2008 Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization Feb 12, 2008 Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Company's Board of Directors Feb 12, 2008 Nektar Therapeutics' President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City Jan 29, 2008 Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction Jan 08, 2008 Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer Jan 08, 2008 Nektar Therapeutics' President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference Jan 02, 2008 Nektar Promotes John Nicholson to Serve as Chief Financial Officer Dec 11, 2007 Pagination First page « first Previous page ‹ previous … Page 44 Page 45 Page 46 Page 47 Current page 48 Page 49 Page 50 Page 51 Page 52 … Next page next › Last page last »